Consistency of safety and efficacy of new oral anticoagulants across subgroups of patients with atrial fibrillation.

Consistency of safety and efficacy of new oral anticoagulants across subgroups of patients with atrial fibrillation.

AIMS: The well-known limitations of vitamin K antagonists (VKA) led to development of new oral anticoagulants (NOAC) in non-valvular atrial fibrillation (NVAF). The aim of this meta-analysis was to determine the consistency of treatment effects of NOAC irrespective of age, comorbidities, or prior VK...

Full description

Bibliographic Details
Main Authors: Jean-Christophe Lega, Laurent Bertoletti, Cyrielle Gremillet, Céline Chapelle, Patrick Mismetti, Michel Cucherat, Denis Vital-Durand, Silvy Laporte, Meta-Embol Group
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2014-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC3951387?pdf=render

Internet

http://europepmc.org/articles/PMC3951387?pdf=render

Similar Items